What bioAffinity Technologies’ $4m financing means for CyPath Lung growth
bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.
bioAffinity Technologies closes $4 million financing as CyPath Lung sales grow. Examine dilution, cash runway and commercial expansion.
HBOT demand is rising beyond hospitals. MD Hyperbaric’s clinic expansion tests whether recovery care can scale without losing clinical rigor.